ArticleTechnology in cancer research & treatment2019

Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.

Ruiqi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.